Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)Yongge Liu, Jeffrey Hafkin, Lawrence Geiter et al.|Tuberculosis|2018Cited by 164
MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical ConcentrationKelly Wallace Stinson, Lawrence Geiter, Natalia Kurepina et al.|Antimicrobial Agents and Chemotherapy|2016Cited by 57
Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant TuberculosisSuresh Mallikaarjun, Yongge Liu, Tawanda Gumbo et al.|Antimicrobial Agents and Chemotherapy|2020Cited by 24